You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 21, 2024

LOSARTAN POTASSIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Losartan Potassium, and when can generic versions of Losartan Potassium launch?

Losartan Potassium is a drug marketed by Aiping Pharm Inc, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, Zydus Pharms Usa Inc, Apotex, Sandoz, and Teva Pharms. and is included in forty NDAs.

The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.

Drug patent expirations by year for LOSARTAN POTASSIUM
Drug Prices for LOSARTAN POTASSIUM

See drug prices for LOSARTAN POTASSIUM

Drug Sales Revenue Trends for LOSARTAN POTASSIUM

See drug sales revenues for LOSARTAN POTASSIUM

Recent Clinical Trials for LOSARTAN POTASSIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gadjah Mada UniversityPhase 1/Phase 2
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
Steadman Philippon Research InstitutePhase 2

See all LOSARTAN POTASSIUM clinical trials

Pharmacology for LOSARTAN POTASSIUM
Medical Subject Heading (MeSH) Categories for LOSARTAN POTASSIUM

US Patents and Regulatory Information for LOSARTAN POTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 091617-003 Feb 17, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Prinston Inc LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 204901-002 Nov 6, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 091541-002 Sep 24, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Jubilant Cadista LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 201170-002 Sep 18, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ipca Labs Ltd LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 201682-002 Mar 1, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.